These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Proceedings of the International Symposium on Omeprazole. Monte-Carlo, Monaco, 11-12 November 1988. Scand J Gastroenterol Suppl; 1989; 166():1-184. PubMed ID: 2602910 [No Abstract] [Full Text] [Related]
4. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Wilde MI; McTavish D Drugs; 1994 Jul; 48(1):91-132. PubMed ID: 7525198 [TBL] [Abstract][Full Text] [Related]
5. Omeprazole. Med Lett Drugs Ther; 1990 Mar; 32(813):19-21. PubMed ID: 2179694 [No Abstract] [Full Text] [Related]
6. Clinical impact of H+, K+-ATP-ase inhibitors. Proceedings of a symposium. Maastricht, November 25, 1988. Digestion; 1989; 44 Suppl 1():1-95. PubMed ID: 2606279 [No Abstract] [Full Text] [Related]
7. Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases. Robinson M Int J Clin Pract; 2005 Jun; 59(6):709-15. PubMed ID: 15924600 [TBL] [Abstract][Full Text] [Related]
8. The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine. Dohil R; Newbury RO; Sellers ZM; Deutsch R; Schneider JA J Pediatr; 2003 Aug; 143(2):224-30. PubMed ID: 12970638 [TBL] [Abstract][Full Text] [Related]
9. [Omeprazole in peptic ulceration: acid inhibition and endoscopic healing]. Chen SP; Mai CR; Ke MY Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):720-1, 767. PubMed ID: 2636088 [TBL] [Abstract][Full Text] [Related]
11. Omeprazole--a more potent suppressor of gastric acid secretion: is it better? Bardan E; Bar-Meir S Isr J Med Sci; 1994 Oct; 30(10):784-6. PubMed ID: 7960694 [No Abstract] [Full Text] [Related]
12. [Omeprazole. A new inhibitor of gastric secretion]. Farup PG Tidsskr Nor Laegeforen; 1989 Aug; 109(22):2156-7. PubMed ID: 2772881 [No Abstract] [Full Text] [Related]
13. [Omeprazole. A new substance for inhibiting acid production]. Uhl D Med Monatsschr Pharm; 1990 Feb; 13(2):34-7. PubMed ID: 2179691 [No Abstract] [Full Text] [Related]
14. Omeprazole: a new approach to gastric acid suppression. Buhl K; Clearfield HR Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497 [TBL] [Abstract][Full Text] [Related]
15. The pharmacology of esomeprazole and its role in gastric acid related diseases. Saccar CL Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1113-24. PubMed ID: 19606942 [TBL] [Abstract][Full Text] [Related]
16. Preanaesthetic oral ranitidine, omeprazole and metoclopramide for modifying gastric fluid volume and pH. Gombar S; Kiran S; Gupta M; Gombar K; Chhabra B Can J Anaesth; 1994 Sep; 41(9):879-80. PubMed ID: 7955016 [No Abstract] [Full Text] [Related]
17. Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders. Creutzfeldt W Drug Saf; 1994 Jan; 10(1):66-82. PubMed ID: 8136088 [TBL] [Abstract][Full Text] [Related]
18. Gastric ulcer despite no acid in a renal allograft recipient: what is the link? Canbakan B; Mizrak D; Keven K; Kaygusuz G; Kutlay S; Sengul S; Erbay B Nephrol Dial Transplant; 2005 Oct; 20(10):2279-81. PubMed ID: 16115851 [No Abstract] [Full Text] [Related]
19. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states]. Bulgakov SA Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266 [No Abstract] [Full Text] [Related]